Intellia Therapeutics
The Strategic Account Liaison will lead the development and execution of strategies for site selection, readiness, and activation to deliver Intellia's one-time CRISPR therapy. The role focuses on building an infusion network, coordinating care pathways, and supporting complex reimbursement and patient access processes across a multi‑state territory.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2014
Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
1 week ago
Intellia Therapeutics: Why The Clinical Hold Lift Isn't A Total Victory (NASDAQ:NTLA)
3 days ago
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Intellia Therapeutics.
23% above the average for this role
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
2 weeks ago
Field Access Manager
BioLife Plasma Services
Associate Director Oncology Treatment Site Lead (TSL)
MSD
Account Manager/Specialty Account Manager - Rare Disease
Amgen
Associate Director, Access & Reimbursement (ADAR) CV- Las Vegas, NV
Novartis
Field Reimbursement Manager - Neurology (Dallas/Houston, TX)
Regeneron Pharmaceuticals
Associate Director, Access & Reimbursement (ADAR) CV- Houston, TX
Novartis